Winton Group LTD Ascendis Pharma A/S Transaction History

Winton Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$127.1 - $169.66 $298,557 - $398,531	-2,349 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$112.67 - $176.92 $264,661 - $415,585	2,349 New	2,349 $374,000
Q2 2021 Aug 10, 2021	SELL	$121.62 - $145.29 $197,389 - $235,805	-1,623 Closed	0 $0
Q1 2021 Jul 21, 2021	BUY	$124.92 - $173.33 $46,595 - $64,652	373 Added 29.84%	1,623 $209,000
Q4 2020 Feb 12, 2021	SELL	$151.2 - $182.76 $331,581 - $400,792	-2,193 Reduced 63.69%	1,250 $208,000
Q3 2020 Oct 30, 2020	BUY	$134.29 - $154.32 $462,360 - $531,323	3,443 New	3,443 $531,000

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.